Midterm stability and hemodynamic performance of a transfemorally implantable nonmetallic, retrievable, and repositionable aortic valve in patients with severe aortic stenosis: Up to 2-year follow-up of the direct-flow medical valve: A pilot study

Circulation: Cardiovascular Interventions

Volumn 4, Issue 6, 2011, Pages 595-601

  Bijuklic, Klaudija ^a   Tuebler, Thilo ^a   Reichenspurner, Hermann ^b   Treede, Hendrik ^b   Wandler, Andreas ^c   Harreld, John H ^d   Low, Reginald I ^e   Schofer, Joachim ^a  

^a Medical Care Center Prof Mathey Prof Schofer   (Germany)

^b UNIVERSITY HEART CENTER HAMBURG   (Germany)

^c Allianz AG   (Germany)

^d Harreld Consulting   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aortic stenosis; Percutaneous aortic valve implantation; Retrievable aortic valve prosthesis

Indexed keywords

AGED; AORTA VALVE PROSTHESIS; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; CLINICAL ARTICLE; DIRECT FLOW MEDICAL AORTA VALVE PROSTHESIS; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PRIORITY JOURNAL; SCORING SYSTEM; SURGICAL RISK; SURVIVAL RATE; SURVIVAL TIME; TRANSCATHETER AORTIC VALVE IMPLANTATION;

AGED; AGED, 80 AND OVER; ANGIOPLASTY; AORTIC VALVE; AORTIC VALVE STENOSIS; ECHOCARDIOGRAPHY; FEMALE; FEMORAL VEIN; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEMODYNAMICS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PILOT PROJECTS; REGIONAL BLOOD FLOW; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84856108582     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.111.964072     Document Type: Article

References (20)

1. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363: 1597-1607.
2. Geisbuesch S, Bleiziffer S, Mazzitelli D, Ruge H, Bauernschmitt R, Lange R. Incidence and management of corevalve dislocation during transcatheter aortic valve implantation. Circ Cardiovasc Interv. 2010;3: 531-536.
3. Webb JG, Pasupati S, Humphries K, Thompson C, Altwegg L, Moss R, Sinhal A, Carere RG, Munt B, Ricci D, Ye J, Cheung A, Lichtenstein SV. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation. 2007;116:I240-I245.
4. Treede H, Tübler T, Reichenspurner H, Grube E, Pascotto A, Franzen O, Mueller R, Low R, Bolling SF, Meinertz T, Schofer J. Six-month results of a repositionable and retrievable pericardial valve for transcatheter aortic valve replacement: the direct flow medical aortic valve. J Thorac Cardiovasc Surg. 2010;140:897-903.
5. Schofer J, Schlüter M, Treede H, Franzen OW, Tübler T, Pascotto A, Low RI, Bolling SF, Meinertz T, Reichenspurner H. Retrograde transarterial implantation of a nonmetallic aortic valve prosthesis in highsurgical- risk patients with severe aortic stenosis: a first-in-man feasibility and safety study. Circ Cardiovasc Interv. 2008;1:126-133.
6. Piazza N, de Jaegere P, Schultz C, Becker AE, Serruys PW, Anderson RH. Anatomy of the aortic valve complex and its implications for transcatheter implantation of the aortic valve. Circ Cardiovasc Interv. 2008; 1:74-81.
7. Schultz C, Moelker A, Tzikas A, Piazza N, de Feyter P, van Geuns RJ, Serruys PW, Krestin GP, de Jaegere P. The use of MSCT for the evaluation of the aortic root before transcutaneous aortic valve implantation: the Rotterdam approach. EuroIntervention. 2010;6:505-511.
8. Zarauza J, Ares M, Vilchez FG, Hernando JP, Gutiérrez B, Figueroa A, Vázquez de Prada JA, Durán RM. An integrated approach to the quantification of aortic regurgitation by Doppler echocardiography. Am Heart J. 1998;136:1030-1041. (Pubitemid 29080862)
9. Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, Krucoff MW, Mack M, Mehran R, Miller C, Morel M, Peterson J, Pompa JJ, Takkenberk J, Vahanian A, van Es G, Vrancky P, Webb JG, Windecker S, Serruys PW. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the valve academic. Eur Heart J. 2011;32:205-217.
10. Abdel-Wahab M, Zahn R, Horack M, Gerckens U, Schuler G, Sievert H, Eggebrecht H, Senges J, Richardt G; German Transcatheter Aortic Valve Interventions Registry Investigators. Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome: results from the German transcatheter aortic valve interventions registry. Heart. 2011; 97:899-906.
11. Bosmans JM, Kefer J, De Bruyne B, Herijgers P, Dubois C, Legrand V, Verheye S, Rodrigus I; Belgian TAVI Registry Participants. Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry. Interact Cardiovasc Thorac Surg. 2011;12:762-767.
12. Eltchaninoff H, Prat A, Gilard M, Leguerrier A, Blanchard D, Fournial G, Iung B, Donzeau-Gouge P, Tribouilloy C, Debrux JL, Pavie A, Gueret P; FRANCE Registry Investigators. Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur Heart J. 2011;32:191-197.
13. Thomas M, Schymik G, Walther T, Himbert D, Lefèvre T, Treede H, Eggebrecht H, Rubino P, Michev I, Lange R, Anderson WN, Wendler O. Thirty-day results of the SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2010; 122:62-69.
14. Webb JG, Chandavimol M, Thompson CR, Ricci DR, Carere RG, Munt BI, Buller CE, Pasupati S, Lichtenstein S. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation. 2006;113: 842-850.
15. Clavel MA, Webb JG, Rodes-Cabau J, Masson JB, Dumont E, De Larochellière R, Doyle D, Bergeron S, Baumgartner H, Burwash IG, Dumesnil JG, Mundigler G, Moss R, Kempny A, Bagur R, Bergler-Klein J, Gurvitch R, Mathieu P, Pibarot P. Comparison between transcatheter and surgical prothesic valve implantation in patients with severe aortic stenosis and reduced left ventricular ejection fraction. Circulation. 2010; 122:1928-1936.
16. Svensson LG, Dewey T, Kapadia S, Roselli EE, Stewart A, Williams M, Anderson WN, Brown D, Leon M, Lytle B, Moses J, Mack M, Tuzcu M, Smith C. Unites States feasibility study of. transcatheter insertion of a stented aortic valve by the left ventricular apex. Ann Thorac Surg. 2008;86:46-54.
17. Tamburino C, Capodanno D, Ramondo A, Petronio AS, Ettori F, Santoro G, Klugmann S, Maisano F, Marzocchi A, Poli A, Antoniucci D, Napodano M, De Carlo M, Fiorina C, Ussia GP. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation. 2011;123:299-308.
18. Sherif MA, Abdel-Wahab M, Stöcker B, Geist V, Richardt D, Tölg R, Richardt G. Anatomic and procedural predictors of paravalvular aortic regurgitation after implantation of the Medtronic CoreValve bioprosthesis. J Am Coll Cardiol. 2010;56:1623-1629.
19. Zahn R, Gerckens U, Grube E, Linke A, Sievert H, Eggebrecht H, Hambrecht R, Sack S, Hauptmann KE, Richardt G, Figulla HR, Senges J; German Transcatheter Aortic Valve Interventions-Registry Investigators. Transcatheter aortic valve implantation: first results form a multi-center real world registry. Eur Heart J. 2011;32:198-204.
20. Zierer A, Wimmer-Greinecker G, Martens S, Moritz A, Doss M. The transapical approach for aortic valve implantation. J Thorac Cardiovacs Surg. 2008;136:948-953.